Alignment Healthcare (NASDAQ:ALHC - Get Free Report) issued its quarterly earnings data on Thursday, May 1st. The company reported ($0.05) earnings per share for the quarter, beating analysts' consensus estimates of ($0.12) by $0.07, Zacks reports. Alignment Healthcare had a negative return on equity of 108.69% and a negative net margin of 5.84%. The company had revenue of $926.93 million during the quarter, compared to analysts' expectations of $889.83 million. During the same quarter in the previous year, the business earned ($0.25) earnings per share. The firm's revenue for the quarter was up 47.5% on a year-over-year basis. Alignment Healthcare updated its FY 2025 guidance to EPS and its Q2 2025 guidance to EPS.
Alignment Healthcare Trading Down 0.5 %
Shares of NASDAQ ALHC traded down $0.07 during trading on Thursday, hitting $15.45. 873,133 shares of the company traded hands, compared to its average volume of 2,738,207. The company has a quick ratio of 1.60, a current ratio of 1.60 and a debt-to-equity ratio of 1.82. Alignment Healthcare has a 1 year low of $6.66 and a 1 year high of $21.06. The firm has a market capitalization of $3.05 billion, a P/E ratio of -20.06 and a beta of 1.32. The company has a 50-day moving average price of $17.36 and a 200-day moving average price of $14.36.
Insider Buying and Selling at Alignment Healthcare
In other Alignment Healthcare news, President Dawn Christine Maroney sold 30,000 shares of the firm's stock in a transaction that occurred on Tuesday, February 18th. The stock was sold at an average price of $13.72, for a total transaction of $411,600.00. Following the completion of the sale, the president now owns 1,576,097 shares in the company, valued at $21,624,050.84. This trade represents a 1.87 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO John E. Kao sold 90,000 shares of the company's stock in a transaction that occurred on Tuesday, February 11th. The shares were sold at an average price of $14.23, for a total value of $1,280,700.00. Following the completion of the transaction, the chief executive officer now directly owns 2,183,100 shares in the company, valued at approximately $31,065,513. The trade was a 3.96 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 2,181,855 shares of company stock valued at $35,166,057 over the last ninety days. Corporate insiders own 6.60% of the company's stock.
Wall Street Analysts Forecast Growth
A number of equities analysts have commented on the stock. Robert W. Baird upped their price objective on shares of Alignment Healthcare from $17.00 to $22.00 and gave the stock an "outperform" rating in a research report on Tuesday, April 15th. William Blair reissued an "outperform" rating on shares of Alignment Healthcare in a report on Friday, February 28th. Stephens reaffirmed an "overweight" rating and issued a $17.00 price objective on shares of Alignment Healthcare in a report on Monday, February 24th. JPMorgan Chase & Co. increased their target price on Alignment Healthcare from $14.00 to $17.00 and gave the stock a "neutral" rating in a research note on Thursday, March 6th. Finally, Piper Sandler raised their price target on Alignment Healthcare from $14.00 to $21.00 and gave the company an "overweight" rating in a report on Tuesday, March 4th. One analyst has rated the stock with a sell rating, three have given a hold rating, seven have issued a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus price target of $17.17.
Check Out Our Latest Analysis on Alignment Healthcare
About Alignment Healthcare
(
Get Free Report)
Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.
Read More
Before you consider Alignment Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Alignment Healthcare wasn't on the list.
While Alignment Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
